Search Results - "Toldi, Jozsef"
-
1
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Published in Current medicinal chemistry (01-01-2017)“…Migraine is a primary headache disorder. Despite numerous studies conducted with the aim to understand the pathophysiology of migraine, several aspects are…”
Get more information
Journal Article -
2
The Therapeutic Impact of New Migraine Discoveries
Published in Current medicinal chemistry (01-01-2019)“…Migraine is one of the most disabling neurological conditions and associated with high socio-economic costs. Though certain aspects of the pathomechanism of…”
Get more information
Journal Article -
3
The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
Published in Journal of the neurological sciences (15-08-2009)“…Abstract The metabolism of tryptophan mostly proceeds through the kynurenine pathway. The biochemical reaction includes both an agonist (quinolinic acid) at…”
Get full text
Journal Article Conference Proceeding -
4
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
Published in International journal of molecular sciences (31-03-2020)“…Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases (NDs), presenting a broad range of symptoms from motor…”
Get full text
Journal Article -
5
Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction
Published in Current topics in medicinal chemistry (01-08-2012)“…A number of neurodegenerative diseases have been associated with potentially neurotoxic alterations in the kynurenine pathway. Due to the potent inhibitory…”
Get more information
Journal Article -
6
Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System
Published in Current medicinal chemistry (01-01-2016)“…Parkinson's disease is a common progressive neurodegenerative disorder presenting with characteristic motor symptoms. Non-motor dysfunctions and therapyrelated…”
Get more information
Journal Article -
7
Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design
Published in Current pharmaceutical design (01-01-2015)“…Though migraine and neurodegenerative disorders have a high socioeconomic impact, their therapeutic management has not been fully addressed. Their…”
Get more information
Journal Article -
8
Kynurenines and drug research
Published in Orvosi hetilap (01-03-2020)“…Currently kynurenines are considered a hot topic, because of their involvement in numerous physiological and pathological processes. The essential amino acid,…”
Get more information
Journal Article -
9
Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat
Published in CNS & neurological disorders drug targets (01-01-2015)“…Probenecid has been widely used in the treatment of gout, but evidence suggests that it may also have antinociceptive effects in different inflammatory and…”
Get more information
Journal Article -
10
Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion
Published in European journal of pharmacology (14-02-2009)“…Various acute brain pathological conditions are characterized by the presence of elevated glutamate concentrations in the brain interstitial fluids. It has…”
Get full text
Journal Article -
11
Kynurenines in the CNS: recent advances and new questions
Published in Nature reviews. Drug discovery (01-01-2013)“…Key Points Kynurenic acid has potentially neuroprotective actions, such as antagonism at NMDA ( N -methyl- D -aspartate) receptors, inhibition of glutamate…”
Get full text
Journal Article -
12
Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability
Published in Drug design, development and therapy (01-01-2013)“…Cortical spreading depression (CSD) involves a slowly-propagating depolarization wave in the cortex, which can appear in numerous pathophysiological…”
Get full text
Journal Article -
13
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Published in Journal of the neurological sciences (15-06-2007)“…Abstract The mitochondria have several important functions in the cell. A mitochondrial dysfunction causes an abatement in ATP production, oxidative damage and…”
Get full text
Journal Article Conference Proceeding -
14
Changing the face of kynurenines and neurotoxicity: therapeutic considerations
Published in International journal of molecular sciences (29-04-2015)“…Kynurenines are the products of tryptophan metabolism. Among them, kynurenine and kynurenic acid are generally thought to have neuroprotective properties,…”
Get full text
Journal Article -
15
Protective effects of glucosamine-kynurenic acid after compression-induced spinal cord injury in the rat
Published in Open life sciences (01-12-2012)Get full text
Journal Article -
16
Species-specific neuronal localization of kynurenine aminotransferase-2 in the mouse cerebellum
Published in Neurochemistry international (01-01-2021)“…The immunohistochemical pattern of kynurenine aminotransferase-2 (KAT-2) - the key role enzyme in the production of neuroactive and neuroprotective kynurenic…”
Get full text
Journal Article -
17
Altered tryptophan metabolism in Parkinson's disease: A possible novel therapeutic approach
Published in Journal of the neurological sciences (15-11-2011)“…Abstract Parkinson's disease (PD) is one of the most common disabling neurodegenerative diseases. Although several therapeutic approaches are available, there…”
Get full text
Journal Article -
18
Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs
Published in Molecules (Basel, Switzerland) (26-09-2019)“…Kynurenic acid (KYNA), a metabolite of tryptophan, as an excitatory amino acid receptor antagonist is an effective neuroprotective agent in case of…”
Get full text
Journal Article -
19
Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets
Published in Journal of Alzheimer's disease (01-01-2014)“…The impairment of glutamatergic neurotransmission plays an important role in the development of Alzheimer's disease (AD). The pathological process, which…”
Get more information
Journal Article -
20
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
Published in Current neuropharmacology (01-02-2016)“…Glutamatergic neurotransmission, of special importance in the human brain, is implicated in key brain functions such as synaptic plasticity and memory. The…”
Get full text
Journal Article